{"node": "root", "content": "Assess need for vancomycin and need for VSDL", "children": [{"node": "A", "content": "If clinically indicated, obtain cultures prior to initiation of vancomycin therapy", "children": [{"node": "B", "content": "Obtain VSDL", "children": [{"node": "C", "content": "Assess reported VSDL based on standard SDL evaluation", "children": [{"node": "Assess patient's clinical response to therapy", "content": "Assess patient's clinical response to therapy", "children": [{"node": "D", "content": "Clinical efficacy of vancomycin therapy?", "children": [{"node": "Yes", "content": "Vancomycin therapy clinically needed and no alternative antibiotic available based on culture results and patient's risk factor?", "children": [{"node": "Yes", "content": "VSDL drawn at steady state (SS)?", "children": [{"node": "Yes", "content": "Two or more levels obtained (i.e., peak and trough)?", "children": [{"node": "Yes", "content": "If clinically indicated, use pharmacokinetic parameters of vancomycin to evaluate levels", "children": [{"node": "F", "content": "Type of dosing regimen"}]}, {"node": "No", "content": "Type of dosing regimen", "children": [{"node": "Type of dosing regimen", "content": "Type of dosing regimen"}]}]}, {"node": "No", "content": "Assess current SDL and need to repeat SDL when vancomycin has reached SS"}]}, {"node": "No", "content": "Consider alternative agents or change in vancomycin dose"}]}, {"node": "No", "content": "VSDL drawn at steady state (SS)?", "children": [{"node": "Yes", "content": "Two or more levels obtained (i.e., peak and trough)?", "children": [{"node": "Yes", "content": "If clinically indicated, use pharmacokinetic parameters of vancomycin to evaluate levels"}, {"node": "No", "content": "Type of dosing regimen"}]}, {"node": "No", "content": "Assess current SDL and need to repeat SDL when vancomycin has reached SS"}]}]}, {"node": "E", "content": "Signs of toxicity or other adverse drug event?", "children": [{"node": "Yes", "content": "Consider alternative agents or change in vancomycin dose"}, {"node": "No", "content": "VSDL drawn at steady state (SS)?", "children": [{"node": "Yes", "content": "Two or more levels obtained (i.e., peak and trough)?"}, {"node": "No", "content": "Assess current SDL and need to repeat SDL when vancomycin has reached SS"}]}]}]}]}]}]}, {"node": "Type of dosing regimen", "content": "Type of dosing regimen", "children": [{"node": "I", "content": "Continuous vancomycin infusion", "children": [{"node": "In general", "content": "In general, any random vancomycin SDL should remain above MIC; depending on site of infection and culture results, random vancomycin SDL should be >5 \u00b5g/ml*", "children": [{"node": "Trough level between 5 and 20", "content": "Trough level between 5 and 20 \u00b5g/ml*"}, {"node": "Trough level >20", "content": "Trough level >20 \u00b5g/ml*"}, {"node": "Trough level <5", "content": "Trough level <5 \u00b5g/ml*"}]}]}, {"node": "G", "content": "Intermittent vancomycin infusion", "children": [{"node": "H", "content": "Evaluate goal level based on type and site of infection", "children": [{"node": "Trough level between 5 and 20", "content": "Trough level between 5 and 20 \u00b5g/ml*"}, {"node": "Trough level >20", "content": "Trough level >20 \u00b5g/ml*"}, {"node": "Trough level <5", "content": "Trough level <5 \u00b5g/ml*"}]}]}]}]}